TPST
Price
$6.24
Change
-$0.06 (-0.95%)
Updated
May 23, 04:21 PM (EDT)
Capitalization
23.16M
76 days until earnings call
VERV
Price
$4.36
Change
+$0.13 (+3.07%)
Updated
May 23, 04:59 PM (EDT)
Capitalization
390.45M
76 days until earnings call
Interact to see
Advertisement

TPST vs VERV

Header iconTPST vs VERV Comparison
Open Charts TPST vs VERVBanner chart's image
Tempest Therapeutics
Price$6.24
Change-$0.06 (-0.95%)
Volume$200
Capitalization23.16M
Verve Therapeutics
Price$4.36
Change+$0.13 (+3.07%)
Volume$38.24K
Capitalization390.45M
TPST vs VERV Comparison Chart
Loading...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TPST vs. VERV commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TPST is a Hold and VERV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 24, 2025
Stock price -- (TPST: $6.30 vs. VERV: $4.38)
Brand notoriety: TPST and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TPST: 1% vs. VERV: 64%
Market capitalization -- TPST: $23.16M vs. VERV: $390.45M
TPST [@Biotechnology] is valued at $23.16M. VERV’s [@Biotechnology] market capitalization is $390.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $307B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TPST’s FA Score shows that 0 FA rating(s) are green whileVERV’s FA Score has 1 green FA rating(s).

  • TPST’s FA Score: 0 green, 5 red.
  • VERV’s FA Score: 1 green, 4 red.
According to our system of comparison, both TPST and VERV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TPST’s TA Score shows that 3 TA indicator(s) are bullish while VERV’s TA Score has 2 bullish TA indicator(s).

  • TPST’s TA Score: 3 bullish, 3 bearish.
  • VERV’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, TPST is a better buy in the short-term than VERV.

Price Growth

TPST (@Biotechnology) experienced а -3.15% price change this week, while VERV (@Biotechnology) price change was +1.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.07%. For the same industry, the average monthly price growth was +3.12%, and the average quarterly price growth was -3.91%.

Reported Earning Dates

TPST is expected to report earnings on Aug 07, 2025.

VERV is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+1.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERV($390M) has a higher market cap than TPST($23.2M). VERV YTD gains are higher at: -22.340 vs. TPST (-41.974). TPST has less debt than VERV: TPST (15.4M) vs VERV (70M).
TPSTVERVTPST / VERV
Capitalization23.2M390M6%
EBITDAN/A-221.91M-
Gain YTD-41.974-22.340188%
P/E RatioN/AN/A-
RevenueN/A32.3M-
Total CashN/A524M-
Total Debt15.4M70M22%
FUNDAMENTALS RATINGS
TPST: Fundamental Ratings
TPST
OUTLOOK RATING
1..100
85
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
88
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TPSTVERV
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend about 1 month ago
82%
Bullish Trend 8 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME30.862.81
+10.02%
GameStop Corp
TSLA341.046.42
+1.92%
Tesla
BTC.X111673.2800001995.203100
+1.82%
Bitcoin cryptocurrency
SPY583.090.23
+0.04%
SPDR® S&P 500® ETF
AAPL201.36-0.73
-0.36%
Apple

TPST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TPST has been loosely correlated with PHIO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TPST jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TPST
1D Price
Change %
TPST100%
N/A
PHIO - TPST
51%
Loosely correlated
+2.79%
ABCZF - TPST
49%
Loosely correlated
N/A
RXRX - TPST
38%
Loosely correlated
+1.22%
VERV - TPST
37%
Loosely correlated
+3.55%
OBIO - TPST
36%
Loosely correlated
-0.36%
More

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with BEAM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
+3.55%
BEAM - VERV
58%
Loosely correlated
N/A
CRSP - VERV
55%
Loosely correlated
+1.46%
RXRX - VERV
51%
Loosely correlated
+1.22%
XNCR - VERV
50%
Loosely correlated
+2.26%
ARWR - VERV
49%
Loosely correlated
+0.52%
More